Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Aerosol: SOP for QA Oversight During Manufacturing Operations – V 2.0

Posted on By

Aerosol: SOP for QA Oversight During Manufacturing Operations – V 2.0

SOP for QA Oversight During Manufacturing Operations

Department Aerosol
SOP No. SOP/Aerosol/088/2025
Supersedes SOP/Aerosol/088/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the responsibilities of Quality Assurance (QA) during aerosol manufacturing operations. The objective is to ensure that the manufacturing process is carried out in compliance with GMP regulations and that the quality of the finished aerosol products meets company standards and regulatory requirements. QA oversight helps identify and mitigate risks during production, ensuring the safety, efficacy, and quality of the product.

2. Scope

This SOP applies to all aerosol manufacturing operations at [Company Name]. It covers the role of QA in monitoring production activities, reviewing records, conducting inspections, and ensuring that all processes comply with quality standards and regulatory requirements.

3. Responsibilities

  • QA Team: Responsible for overseeing manufacturing operations, ensuring compliance with GMP guidelines, conducting in-process inspections, reviewing batch records, and approving or rejecting finished products based on quality standards.
  • Production Team: Responsible for executing manufacturing processes according to approved procedures, documenting production activities, and reporting any deviations or non-conformances to the QA team.
  • Maintenance Team: Ensures that all equipment used in manufacturing is properly maintained and calibrated, and that it operates within specified parameters.
  • Regulatory Affairs Team: Ensures that manufacturing operations meet all relevant regulatory requirements and that any necessary reporting or compliance activities are completed.

4. Accountability

The Manufacturing Manager is accountable for ensuring that all manufacturing operations are conducted in compliance with this SOP. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

See also  Aerosol: SOP for Weighing and Dispensing Raw Materials - V 2.0

5. Procedure

5.1. QA Oversight Planning

  1. Before production begins, the QA team will review the production schedule, batch records, and relevant documentation to ensure that all required materials, equipment, and processes are in place.
  2. QA will ensure that personnel involved in the manufacturing process are trained in GMP and the specific procedures for the batch being produced.
  3. QA will confirm that all equipment used in the manufacturing process is calibrated and maintained according to established procedures.
  4. The QA team will ensure that appropriate in-process tests and inspections are scheduled throughout the manufacturing process.

5.2. Monitoring Production Activities

  1. During the manufacturing process, the QA team will conduct periodic inspections of the production areas, including:
    • Inspecting equipment and manufacturing areas for cleanliness and suitability.
    • Monitoring in-process testing (e.g., fill weights, pressure testing, particle size analysis) to ensure that product specifications are being met.
    • Ensuring that production personnel are following approved procedures and work instructions.
  2. QA will document all inspections and observations, noting any discrepancies or non-compliance issues. If any deviations are found, they must be reported to the production team immediately.
  3. Any non-conformance issues observed during the inspection should be addressed promptly by the production team, and corrective actions should be documented in the Deviation Log (Annexure-1).

5.3. Review of Batch Records

  1. After each production batch is completed, the QA team will review the batch records to ensure that all required documentation is complete and accurate. The batch records should include:
    • Raw material usage
    • Process parameters (e.g., temperature, pressure, speed)
    • In-process test results
    • Operator and supervisory signatures
    • Any deviations or non-conformances and associated corrective actions
  2. QA will ensure that all batch records are complete and that any deviations have been properly investigated and resolved before the batch is released for packaging.
  3. If the batch records are incomplete or inaccurate, QA will request additional information or clarification before approving the batch.
See also  Aerosol: SOP for Temperature and Humidity Monitoring in Stability Chambers - V 2.0

5.4. Product Release

  1. Before a finished batch is released for packaging, the QA team will conduct a final review of the batch records, in-process test results, and cleaning validation data (if applicable).
  2. If all quality standards have been met and no issues remain, the QA team will approve the batch for release to packaging.
  3. If any discrepancies or issues are identified during the final review, the batch will not be approved until corrective actions have been taken. The QA team will document these issues in the Non-Conformance Log (Annexure-2).

5.5. Reporting and Documentation

  1. The QA team will maintain comprehensive records of all oversight activities, including in-process inspections, batch record reviews, and product approvals.
  2. All reports and documentation related to QA oversight must be stored in the document management system for easy access and future reference.
  3. QA will provide regular reports to management on the status of manufacturing operations, including any issues or concerns related to product quality and regulatory compliance.

5.6. Corrective and Preventive Actions

  1. If any deviations or non-compliance issues are identified during QA oversight, corrective actions must be implemented immediately. Corrective actions may include:
    • Investigating the root cause of the deviation.
    • Implementing changes to manufacturing procedures or equipment.
    • Providing retraining for personnel.
  2. Preventive actions should also be considered to prevent recurrence of the same issue. These may include process improvements, additional testing, or enhanced monitoring procedures.
  3. All corrective and preventive actions must be documented in the Corrective Action Log (Annexure-3), including the person responsible, due date, and status of the action.
See also  Aerosol: SOP for Line Clearance Before Starting Aerosol Manufacturing - V 2.0

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • PPE: Personal Protective Equipment
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance

7. Documents

  1. Deviation Log (Annexure-1)
  2. Non-Conformance Log (Annexure-2)
  3. Corrective Action Log (Annexure-3)

8. References

This SOP is based on the following regulatory guidelines and industry standards:

  • Good Manufacturing Practice (GMP) Guidelines
  • FDA Code of Federal Regulations (CFR) Title 21, Part 211
  • ISO 9001:2015 – Quality Management Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Log

Deviation ID Deviation Description Corrective Action Operator Name Approval
DEV-12345 Underfill detected Adjusted filling machine settings Rajesh Patel Approved

Annexure-2: Non-Conformance Log

Non-Conformance ID Non-Conformance Description Corrective Action Responsible Person Status
NC-001 Improper temperature during filling Re-calibrated temperature control Rajesh Patel Completed

Annexure-3: Corrective Action Log

Deviation ID Corrective Action Implementation Date Responsible Person Status
DEV-12345 Re-calibrated filling machine 07/02/2025 Rajesh Patel Completed

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
01/01/2025 V 2.0 Updated QA oversight procedures To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

Post navigation

Previous Post: SOP for Routine Checks for Material Integrity in Storage – V 2.0
Next Post: Capsule: SOP for Validation of Cleaning Procedures for Drying Trays and Racks – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version